BACKGROUND: For many childhood cancers, survival is lower among non-Hispanic blacks and Hispanics in comparison with nonHispanic whites, and this may be attributed to underlying socioeconomic factors. However, prior childhood cancer survival studies have not formally tested for mediation by socioeconomic status (SES). This study applied mediation methods to quantify the role of SES in racial/ethnic differences in childhood cancer survival. METHODS: This study used population-based cancer survival data from the Surveillance, Epidemiology, and End Results 18 database for black, white, and Hispanic children who had been diagnosed at the ages of 0 to 19 years in 2000-2011 (n 5 31,866). Black-white and Hispanic-white mortality hazard ratios and 95% confidence intervals, adjusted for age, sex, and stage at diagnosis, were estimated. The inverse odds weighting method was used to test for mediation by SES, which was measured with a validated census-tract composite index. RESULTS: Whites had a significant survival advantage over blacks and Hispanics for several childhood cancers. SES significantly mediated the race/ethnicity-survival association for acute lymphoblastic leukemia, acute myeloid leukemia, neuroblastoma, and non-Hodgkin lymphoma; SES reduced the original association between race/ethnicity and survival by 44%, 28%, 49%, and 34%, respectively, for blacks versus whites and by 31%, 73%, 48%, and 28%, respectively, for Hispanics versus whites ((log hazard ratio total effect -log hazard ratio direct effect)/log hazard ratio total effect). CONCLUSIONS: SES significantly mediates racial/ethnic childhood cancer survival disparities for several cancers. However, the proportion of the total race/ethnicity-survival association explained by SES varies between black-white and Hispanic-white comparisons for some cancers, and this suggests that mediation by other factors differs across groups.
INTRODUCTION
Despite improvements over the last 4 decades in cancer survival in the US pediatric population, marked racial and ethnic disparities persist. 1 Compared with non-Hispanic white (white) children, non-Hispanic black (black) and Hispanic children experience lower survival from many cancers, including leukemias, 2,3 lymphomas, 4,5 central nervous system (CNS) tumors, 6 and extracranial solid tumors. [7] [8] [9] The underlying causes of racial/ethnic survival differences are not well understood and may vary by cancer type. As outlined in Figure 1 , both biological and socioeconomic pathways have been proposed in the literature. 10, 11 Underlying genetic variations associated with ancestry may lead to differences in tumor biology and pharmacogenetics for some childhood cancers. 10 However, race/ethnicity is a socially constructed taxonomy that is not synonymous with ancestry. 12 Race/ethnicity is highly correlated with socioeconomic status (SES), especially in the United States, where embedded, institutionalized racism continues to place racial and ethnic minorities at high risk for low SES. 13 Because of emerging evidence for a positive association between SES and survival from some childhood cancers, 11 racial/ethnic survival disparities may also be explained by socioeconomic differences. Quantifying the relative role of SES in explaining racial/ethnic survival disparities will help to inform practice and intervention efforts. If SES accounts for racial/ethnic survival differences, then interventions addressing social and economic barriers to treatment and care are warranted. However, if SES does not fully account for survival differences by race/ethnicity, then other social factors (eg, immigration) and biological mechanisms (eg, tumor biology) must be considered. To date, formal mediation methods have not been used to disentangle racial/ethnic disparities in childhood cancer survival. Therefore, we conducted a mediation analysis using population-based data, representative of the US pediatric cancer population, to measure the role of SES in racial and ethnic childhood cancer survival disparities. We assessed survival from several childhood cancers to determine whether mediation by SES differs across cancer types.
MATERIALS AND METHODS

Study Population
We obtained population-based cancer registry data from the Surveillance, Epidemiology, and End Results (SEER) 18 database; the Alaska Native Tumor Registry was excluded. We restricted the analysis to black, Hispanic, and white cases aged 0 to 19 years with microscopically confirmed first primary malignancies. Race was assigned in SEER through medical record abstraction. 14, 15 Hispanic ethnicity was assigned in SEER on the basis of selfreport/guardian report of Spanish origin in the medical record or by a computer algorithm that searches surnames and maiden names to determine Spanish origin.
14, 16 We assessed race/ethnicity with mutually exclusive categories (non-Hispanic white, non-Hispanic black, and Hispanic); individuals of Spanish origin were categorized as Hispanic, regardless of racial background. SES data were available in SEER for diagnostic years 2000-2012. Therefore, we restricted our sample to cases diagnosed in 2000-2011 and followed through December 31, 2012, to allow for at least 1 year of follow-up. We excluded 45 cases with in situ tumors, 707 cases with missing/zero months of follow-up, and 725 cases missing SES data. We assessed cancers with 200 cases for each racial/ethnic group; they were classified with the International Classification of Childhood Cancer, third edition. 17 Our final analytic sample consisted of 31,866 cases. This study was approved by the Surveillance Research Program in the National Cancer Institute's Division of Cancer Control and Population Sciences.
Measures
Overall survival was calculated in SEER as months from the date of the cancer diagnosis to the date of death from any cause or was censored at the date of last contact.
SES was measured at the neighborhood level (based on the residential address at the date of the cancer diagnosis) with a validated census-tract composite index. 18 As described in the prior literature, 19 the index was constructed through a factor analysis of nationwide 2000 decennial census data and 2005-2009 American Community Survey data. 18 Seven indicators of neighborhood SES, previously specified by Yost et al, 20 were included in the index: proportion employed in working-class occupations, proportion aged 16 years or older and unemployed, education index, 21 18 The index is available in SEER as a 5-level variable categorized into quintiles (quintile 1 is the lowest SES quintile, and quintile 5 is the highest SES quintile).
As for covariates, we controlled for diagnostic age group (<1, 1-4, 5-9, 10-14, or 15-19 years), sex, and stage at diagnosis (SEER Summary Stage 2000 [19981] : localized, regional, distant, or unknown/unstaged). 22 
Statistical Analysis
For each cancer type, we estimated black-white and Hispanic-white mortality hazard ratios (total effects) from multivariate Cox proportional hazards regression models. No substantial violations of the proportional hazards assumption were identified. For cancers with a statistically significant total effect, we used the inverse odds weighting (IOW) method to test for mediation by SES. 23, 24 IOW analyses were conducted separately for black-white and Hispanic-white comparisons to account for the possibility that SES may mediate differently by race/ethnicity, although sensitivity analyses using multinomial models of all 3 racial/ethnic groups documented comparable results. IOW is a semiparametric, weight-based approach that overcomes many limitations of traditional parametric mediation methods. 25 For example, IOW is appropriate for any functional form (rather than just linear models), can test multiple mediators simultaneously (as opposed to testing them one by one), and is valid even in the presence of exposure-mediator interactions. 26 Applying the IOW method, we estimated the natural 27 direct effect (hereafter called the direct effect) of race/ ethnicity on survival by fitting a weighted, multivariate Cox proportional hazards model. Weighting by the inverse odds of exposure creates a pseudo-population in which the exposure and the mediator are independent; thus, the race/ethnicity-survival association (direct effect) that remains after accounting for the pathway through SES is estimated. To obtain the IOW weights, we first estimated the odds of exposure (ie, race/ethnicity) for each subject from a multivariate logistic regression model specifying SES and covariates. We then took the inverse of the predicted odds to create the IOW weight for whites; nonwhites were assigned a weight of 1. The nonwhite racial/ethnic group was selected as the reference to minimize extreme weighting values. Next, we estimated the natural 27 indirect effect (hereafter called the indirect effect) of race on survival operating through SES by subtracting the direct effect (log hazard ratio [b] ) from the total effect and bootstrapping to obtain standard errors (500 replications). A significant indirect effect provides statistical evidence of mediation. To quantify the magnitude of mediation by SES, we calculated the percent reduction from the total effect to the direct effect ((b total -b direct )/b total ). Statistical significance was determined as P < .05 for a 2-sided hypothesis test. Analyses were performed with Stata 14.2 (StataCorp, College Station, Texas). 28 
Secondary analyses
The tract-level SES index likely captures an array of socioeconomic factors contributing to survival. One such factor may be health insurance status. To empirically test this, we compared indirect effects of mediation by tract SES index and also by individual-level health insurance status (private vs otherwise); we tested each of these mediators separately and simultaneously. This analysis was confined to cancers with a significant indirect tract SES effect in the primary analysis and to cases diagnosed in 2007-2011, when health insurance data were available in SEER. We also explored whether we inadvertently overly adjusted IOW models by including the stage at diagnosis as a covariate. The stage at diagnosis could theoretically operate as a downstream mediator of the SES-survival association if, for example, SES influences diagnostic timing. 10 We tested logistic models of SES predicting tumor stage (local vs otherwise and distant vs otherwise), and we compared SES indirect-effect estimates from IOW models unadjusted and adjusted for the stage at diagnosis.
RESULTS
Descriptive characteristics by cancer type are provided in Table 1 . All-cause mortality from 2000 to 2012 varied across cancers, ranging from 5.2% among Hodgkin lymphoma (HL) cases to 33.8% among acute myeloid leukemia (AML) cases. The mean age at diagnosis varied across cancers, ranging from 2.5 years (standard deviation, 3.3 years) among neuroblastoma cases to 14.9 years (standard deviation, 3.8 years) among HL cases. There was a higher proportion of males versus females for all cancers except for Wilms tumors (53.4% female). The distribution of tumor stages varied across cancers (stage does not apply to leukemias). For example, only 1.9% of astrocytoma cases were classified as distant stage at diagnosis, whereas 48.9% of neuroblastoma cases were. The distribution of cases across SES categories was consistent across cancers. Sample characteristics by race/ethnicity are available in the supporting information (Supporting Table 1 ).
In Table 2 , we compare all-cause mortality between black and white cases (total effects). For cancers with significant total effects, we also present IOW results for mediation by SES. Compared with whites, black cases had a statistically significant higher hazard of death for all cancers except Wilms tumors, osteosarcomas, and germ cell tumors. Across the 9 cancers with significant racial disparities in mortality, black children exhibited a 38% (neuroblastoma) to 95% (astrocytoma) higher risk of mortality in comparison with white children (P < .05). SES was determined to be a significant mediator of the Higher quintiles represent higher SES (ie, Q1 is the lowest SES quintile, and Q5 is the highest SES quintile).
race-survival association if the indirect effect of race on survival operating through SES was statistically significant. SES significantly mediated the black-white survival disparity for acute lymphoblastic leukemia (ALL; indirect-effect hazard ratio [iHR], 1.17; 95% confidence interval [CI], 1.07-1.28; P < .01; 44% reduction from the total effect to the direct effect of the racial disparity in mortality), AML (iHR, 1.15; 95% CI, 1.03-1.29; P 5 .01; 28% reduction), and neuroblastoma (iHR, 1.17; 95% CI, 1.03-1.33; P 5 .02; 49% reduction). SES was a marginally significant mediator of the black-white survival disparity for non-Hodgkin lymphoma (NHL; iHR, 1.16; 95% CI, 0.97-1.37; P 5 .10; 34% reduction). Firstleg mediation results are available in the supporting information (Supporting Table 2 ). In Table 3 , comparing all-cause mortality between Hispanic and white cases, we present total effects and IOW results for testing mediation by SES. Compared with whites, Hispanic cases had a statistically significantly or marginally significantly (AML and nonrhabdomyosarcoma soft-tissue sarcomas) higher hazard of death for all cancers except HL, non-astrocytoma CNS tumors, rhabdomyosarcoma, and osteosarcoma. Among the 6 cancers exhibiting significant ethnic disparities in mortality, Hispanic children, compared with their white counterparts, exhibited a 31% (neuroblastoma) to 65% (NHL) higher risk of mortality (P < .05). SES significantly mediated the ethnic mortality disparity for ALL (iHR, 1.16; 95% CI, 1.08-1.26; P < .001; 31% reduction from the total effect to the direct effect of the ethnic disparity in mortality), AML (iHR, 1.13; 95% CI, 1.03-1.25; P 5 .01; 73% reduction), neuroblastoma (iHR, 1.14; 95% CI, 1.03-1.26; P 5 .01; 48% reduction), and NHL (iHR, 1.15; 95% CI, 1.01-1.31; P 5 .04; 28% reduction). Notably, SES significantly mediated both the racial and ethnic disparities in survival for the same 4 cancers.
Secondary Analyses
Except for NHL, the mediating effect of tract-level SES was greater than the mediating effect of health insurance status among black-white and Hispanic-white comparisons (Supporting Table 3 ). For example, the indirect effect of tract SES on the black-white mortality disparity for ALL was 1.22 (95% CI, 1.01-1.48; P 5 .04; 44% reduction), whereas the indirect effect of health insurance was 1.09 (95% CI, 0.94-1.27; P 5 .24; 19% reduction). Among cancers with significant SES indirect effects, SES was not associated with the stage at diagnosis (Supporting Table 4 ). The exclusion of the stage at diagnosis from IOW models did not lead to notably stronger indirect SES effects (Supporting Tables 5 and 6 ).
DISCUSSION
This is the first study to use formal mediation methods to unpack childhood cancer survival disparities by race/ethnicity, and it generated several findings. We replicated results from prior studies showing that whites have a significant survival advantage over blacks and Hispanics for several childhood cancers, including leukemias, 2,3 lymphomas, 4 ,5 CNS tumors, 6 neuroblastomas, 7 and nonrhabdomyosarcoma soft-tissue sarcomas. 9 In no instance was survival among whites significantly worse than that of either black or Hispanic children. Racial and ethnic survival differences were not uniform across cancers, and some variability between black-white and Hispanic-white comparisons was observed.
We demonstrated that SES significantly mediates racial/ethnic survival disparities for several childhood cancers, including ALL, AML, neuroblastoma, and NHL. For these cancers, indirect hazard ratios fell within a narrow range (1.13-1.17) for both black-white and Hispanicwhite comparisons. This suggests that the association between SES and survival is not modified by, and may be shared across, race/ethnicity. Conversely, the proportion of the overall survival disparity explained by SES (ie, the percent reduction) did vary by race/ethnicity for some cancers. For example, among AML cases, SES explained only 28% of the black-white survival disparity but 73% of the Hispanic-white disparity. This may suggest a differential role of other mediating factors across racial/ethnic groups for some cancers. For example, prior evidence suggests that, among AML cases, a significantly lower proportion of black children have matched family donors available in comparison with white and Hispanic children. 29 Among other cancers with significant racial/ethnic survival disparities (eg, CNS tumors and soft-tissue sarcomas), we found no significant evidence of mediation by SES. Thus, for these cancers in particular, we cannot rule out mediation by other factors such as differences in tumor biology, pharmacogenomics, health care quality, and other social factors not captured by the SES index (eg, racism). 30 Because SES did not uniformly influence survival across different types of childhood cancer, the mechanisms through which SES influences survival may be cancer-specific. For example, the strong association between SES and ALL survival may be explained by differences in treatment adherence. 10 Unlike treatments for other childhood cancers, the treatment of ALL requires a prolonged maintenance phase composed of the oral administration of antimetabolites, which may be difficult for low-SES families to adhere to because of social and economic constraints. 10 This is supported by prior evidence of lower treatment adherence among children with ALL living in a single-mother household versus a 2-parent household. 31 Other cancer-specific mechanisms through which SES may influence survival are less understood. Secondary findings from this study suggest that factors beyond health insurance status and stage at diagnosis contribute to the SES-survival association, at least for some childhood cancers. Additional research is needed to further unpack the association between SES and childhood cancer survival.
Limitations
We relied on an area-based variable as our primary measure of SES because of the lack of individual-level SES measures in SEER data; moreover, we selected an SES index to operationalize the SES construct over a meaningful period of time. Although this improves upon many prior population-based cancer studies that lacked any measures of SES or relied on county-level measures, tract-level SES is still a proxy for individual-level SES in this study because we could not comprehensively control for SES at the individual level. 32, 33 Furthermore, we used a fairly crude measure of individual-level health insurance status (private vs otherwise) in our secondary analysis. Because the tract-level SES index was available in SEER only for the years 2000-2012, the sample size and the follow-up time were limited. This prevented us from testing more homogenized cancer and racial/ethnic subgroups or stratifying by age. Additional research is thus needed for other smaller populations of racial and ethnic groups not considered in this analysis because of the rarity of childhood cancer, which limited power. We also lacked geographic variables to explore potential spatial variations in survival. Furthermore, the lack of clinical data in SEER limited our ability to account for diagnostic, therapeutic, and biological factors, such as cytogenetic or molecular features. Finally, there is the potential for differential loss to follow-up by race and SES.
In conclusion, through the application of formal mediation methods, we have demonstrated that SES significantly contributes to racial and ethnic survival disparities for several childhood cancers, including ALL, AML, neuroblastoma, and NHL. Thus, for these cancers in particular, racial/ethnic survival disparities could theoretically be addressed through initiatives that reduce social and economic barriers to effective care. Such efforts may include expanded health insurance coverage, improved patient care coordination, increased health literacy, and supplementation of transportation and childcare costs during treatment. However, because SES did not fully account for survival disparities, we cannot rule out the potential role of other mediating pathways, including tumor biology, pharmacogenomics, health care quality, and other social factors. A multipronged intervention approach that both addresses socioeconomic barriers to care and invests in personalized treatment regimens may ultimately be needed to fully eliminate childhood cancer survival disparities.
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